Affiliation:
1. Institute of Psychiatry and Neurology
2. Medical University of Warsaw: Warszawski Uniwersytet Medyczny
Abstract
Abstract
Muscular dystrophy is a group of heterogeneous diseases that cause progressive muscle weakness and atrophy. Many types of muscular dystrophy is distinguished involving Duchenne/Becker, myotonic, limb-girdle, congenital, or facioscapulohumeral muscular dystrophies. Different molecular techniques, including next-generation sequencing (NGS) were performed to identify the genetic cause of Polish patient with limb–girdle muscle weakness and atrophy. Homozygous pathogenic mutation c.550delA, (p.Thr184ArgfsTer36) in the CAPN3 gene as well as a heterozygous expansion of a CCTG repeat of the CNBP gene in this patient had been identified. Segregation analysis showed both maternal and paternal heterozygous carriers for CAPN3 mutation, and a maternally inherited CNBP expansion. Here, we report on the first patient who carried both a homozygous mutation in the CAPN3 and CCTG expansion in the CNBP gene, suggesting the co-occurrence of recessive limb-girdle muscular dystrophy 1 and myotonic dystrophy 2 (DM2) in a single patient. In general, this phenomenon is considered as uncommon, although is possible and, therefore, should be taken into consideration in those populations with a relatively high prevalence of DM2.
Publisher
Research Square Platform LLC
Reference10 articles.
1. Angelini C, Fanin M (2005) [updated 2017 Aug 3] Calpainopathy In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. PMID: 20301490
2. SCN4A as modifier gene in patients with myotonic dystrophy type 2;Binda A;Sci Rep,2018
3. SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype;Bugiardini E;Neuromuscul Disord,2015
4. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2;Cardani R;J Neurol,2012
5. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2;Montagnese F;J Neurol,2017